Showing results (1-10 of 161) with videos related to
Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|April 28, 2009
Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworksGavin A Whitlock, Paul E Brennan, Lee R Roberts, et al.Bioorganic & Medicinal Chemistry Letters|November 5, 2008
Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonistsLee R Roberts, Justin Bryans, Kelly Conlon, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonistsGavin A Whitlock, Kelly Conlon, Gordon McMurray, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2007
N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitorsPaul V Fish, M Jonathan Fray, Alan Stobie, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2008
Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuityGavin A Whitlock, Paul V Fish, M Jonathan Fray, et al.Bioorganic & Medicinal Chemistry Letters|June 6, 2006
Structure-activity relationships of N-substituted piperazine amine reuptake inhibitorsM Jonathan Fray, Gerwyn Bish, Paul V Fish, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2009
4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationshipsPaul V Fish, Mark D Andrews, M Jonathan Fray, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2009
6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonistsLee R Roberts, Paul V Fish, R Ian Storer, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitorsFlorian Wakenhut, Paul V Fish, M Jonathan Fray, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinencePaul E Brennan, Gavin A Whitlock, Danny K H Ho, et al.Pageof 17